Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Cancer treatment reports

• Publication date

  1981-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 6944156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.

  1979cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.

  1979cited by this paper
• Nephrotoxicity of cis‐platinum (II) dichlorodiammine

  1978cited by this paper
• Platinum nephrotoxicity.

  1978cited by this paper
• Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group study.

  1978cited by this paper
• cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.

  1978cited by this paper
• Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.

  1977cited by this paper
• High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis

  1977cited by this paper
• Cis-diamminedichloroplatinum (II). A new anticancer drug.

  1977cited by this paper
• Possible mechanisms for the antitumor activity of platinum coordination complexes.

  1975cited by this paper
• Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.

  1975cited by this paper
• Coordination complexes of platinum as antitumor agents.

  1975cited by this paper
• The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.

  1974cited by this paper
• Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.

  1973cited by this paper

• Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults

  2022cites this paper
• Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy

  2019cites this paper
• Front‐line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group

  2017cites this paper
• Pediatric Osteosarcoma: An Updated Review

  2017cites this paper
• Platinum-induced hearing loss after treatment for childhood cancer.

  2016cites this paper
• Bark extract mediated green synthesis of silver nanoparticles: Evaluation of antimicrobial activity and antiproliferative response against osteosarcoma.

  2016cites this paper
• Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

  2016cites this paper
• Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

  2016cites this paper
• Challenges in ototoxicity monitoring in the pediatric oncology population.

  2014cites this paper
• Dramatic Response to Cisplatin Window Therapy in a Boy With Advanced Metastatic Ewing Sarcoma

  2013cites this paper
• Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma

  2013cites this paper
• Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.

  2012cites this paper
• The role of LKB1 in the pathogenesis of Osteosarcoma

  2011cites this paper
• Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?

  2011cites this paper
• Selective Cytotoxicity against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin Is Potentiated by Curcumin

  2011cites this paper
• Caffeine-potentiated chemotherapy for metastatic osteosarcoma

  2009cites this paper
• Gene and Virotherapy Against Osteosarcoma

  2009cites this paper
• Initial testing of cisplatin by the pediatric preclinical testing program

  2008influential citation
• Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat

  2008cites this paper
• Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

  2008cites this paper
• Cytotoxic effects of curcumin on osteosarcoma cell lines

  2008cites this paper
• High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.

  2008cites this paper
• International collaboration is feasible in trials for rare conditions: the EURAMOS experience.

  2007cites this paper
• EFFECTS OF HYPERBILIRUBINEMIA ON CISPLATIN NEPHROTOXICITY By KARRI ANN BARABAS A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA

  2007cites this paper
• Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors.

  2007cites this paper
• Metastatic osteosarcoma

  2006cites this paper
• Drug-Induced Hypomagnesaemia

  2005cites this paper
• Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin

  2004cites this paper
• Delaying surgery with chemotherapy for osteosarcoma of the extremities

  2004cites this paper
• Cerebral herniation in patients receiving cisplatin

  2004cites this paper
• Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors

  2004cites this paper
• VIP (Etoposide, Ifosfamide, Cisplatin) in Adult Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors

  2004cites this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004cites this paper
• Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary

  2003cites this paper
• Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial.

  2001cites this paper
• Ewing Tumour

  2001cites this paper
• Chemotherapy of thymomas and thymic carcinomas.

  2001cites this paper
• Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V

  2001cites this paper
• Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.

  2000cites this paper
• Nonsurgical management of malignant thymoma

  1999cites this paper
• High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.

  1998cites this paper
• Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.

  1998cites this paper
• A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow

  1997cites this paper
• Long-term survivors of childhood cancer. The medical consequences of cure.

  1997cites this paper
• Long-term survivors of childhood cancer. The medical consequences of cure.

  1997cites this paper
• The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue.

  1997cites this paper
• Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with carboplatin, epirubicin and vincristine.

  1996cites this paper
• The management of relapsed Wilms tumor.

  1995cites this paper
• Use of intracavitary cisplatin for the treatment of childhood solid tumors in the chest or abdominal cavity.

  1995cites this paper
• Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity

  1995cites this paper
• A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

  1994cites this paper
• Bösartige Erkrankungen im Kindes- und Jugendalter

  1994cites this paper
• Cisplatin nephrotoxicity.

  1994cites this paper
• What is the place of carboplatin in paediatric oncology?

  1994cites this paper
• Refining therapeutic strategies for patients with resistant Wilm's tumor.

  1994cites this paper
• A phase I study of carboplatin in children with acute leukemia in bone marrow relapse: A report from the childrens cancer group

  1993cites this paper
• [Platinum derivatives in pediatric oncology].

  1993cites this paper
• Extremity rhabdomyosarcoma: biological principles, staging, and treatment.

  1993cites this paper
• Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdp.

  1993cites this paper
• Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues.

  1993cites this paper
• Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas.

  1992cites this paper
• Renal Salt Wasting in Patients Treated with High-Dose Cisplatin, Etoposide, and Mitomycin in Patients with Advanced Non-Small Cell Lung Cancer

  1992cites this paper
• High-dose rapid schedule chemotherapy for disseminated neuroblastoma.

  1992cites this paper
• Cis‐platinum ototoxicity in children

  1991cites this paper
• Cis‐Platinum ototoxicity in children

  1991cites this paper
• Clinical oncology: case presentations from oncology centres. 1. Ewing's sarcoma. The London Bone Tumour Service.

  1991cites this paper
• Rhabdomyosarcoma. From the laboratory to the clinic.

  1991cites this paper
• High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.

  1990cites this paper
• Chemotherapy of Recurrent Esthesioneuroblastoma: Case Report and Review of the Literature

  1990cites this paper
• Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemia.

  1990cites this paper
• A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors.

  1990cites this paper
• Chemotherapy for Invasive Thymomas

  1990cites this paper
• [Ototoxicity of cisplatin in children with malignant diseases].

  1989cites this paper
• Transcatheter Management of Neoplams

  1989cites this paper
• The Kidney and the Bladder

  1989cites this paper
• Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcoma.

  1989cites this paper
• Ototoxizität von Cisplatin bei Kindern mit malignen Erkrankungen

  1989cites this paper
• Tracing expert thinking in clinical trial design.

  1989cites this paper
• Idea Analysis: A New Approach in Using Scientific Literature

  1989cites this paper
• The role of methotrexate in osteosarcoma.

  1988cites this paper
• Intra-arterial treatment of primary bone tumors

  1988cites this paper
• Rhabdomyosarcoma of childhood.

  1988cites this paper
• Cis-platinum ototoxicity after radiation treatment: an animal model

  1988cites this paper
• Disease patterns and survival rate in children with metastatic soft‐tissue sarcoma: A report from the intergroup rhabdomyosarcoma study (IRS)‐I

  1988cites this paper
• ‘High dose’ cisplatinum: a phase II study

  1987cites this paper
• [Studies of heterotransplantation of transplantable human urogenital malignant neoplasms. Part VIII. Chemotherapy of human Wilms' tumor transplantable to nude mice].

  1987cites this paper
• Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma.

  1987cites this paper
• Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group.

  1987cites this paper
• Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas.

  1987cites this paper
• Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

  1987cites this paper
• High-dose cisplatin and etoposide in advanced malignancies of childhood.

  1987cites this paper
• Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.

  1987cites this paper
• Cis-platinum (CDDP) plus etoposide (VP-16-213) and treatment of disseminated neuroblastoma.

  1986cites this paper
• Modern trends in the management of hepatocellular carcinoma.

  1986cites this paper
• Primary site as a prognostic variable for children with pelvic soft tissue sarcomas.

  1986cites this paper
• Hepatoblastoma and Hepatocellular Carcinoma

  1985cites this paper
• Long Term Complications of Therapy

  1985cites this paper
• Yolk Sac Tumor

  1985cites this paper
• Alveolar rhabdomyosarcoma of the female genitalia

  1985cites this paper
• High-dose cisplatin therapy in ovarian cancer.

  1985cites this paper